Migraine Minute News Update

Celebrating the Fourth of July with migraine is not easy. This festive holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O'Brien shares tips to help you enjoy the celebration while protecting your health.  Check out our triggers webpage: https://bit.ly/4kFOZRf   Script:  While the Fourth of July can be a fun holiday to celebrate in the States, it can...

Why does fighting migraine stigma matter? That stigma we face may be more harmful than many people realize. Research shows increased stigma is linked with higher disease burden. Molly O'Brien breaks it all down in this Migraine Minute News Update. Read the study:  https://bit.ly/4f8J6wv   Script:  June is Migraine and Headache Awareness Month, and you're likely going to hear a lot about fighting m...

A new study shows body pain is more common and widespread in people with migraine or tension-type headache, and may be linked to a greater disease burden. Molly O'Brien breaks down the study in this Migraine Minute News Update. Read more:  https://bit.ly/41BVe10   Script:  According to a study published in the Journal of Headache and Pain, body pain is more prevalent and widespread in people with...

According to a study in the New England Journal of Medicine, fremanezumab led to a greater reduction in migraine days per month than placebo in children and adolescents with episodic migraine. Molly O'Brien breaks down the study in this Migraine Minute News Update. Read the study:  https://bit.ly/4csROT5 Script: In August of 2025, the FDA approved fremanezumab, sold under brand name Ajovy, for pre...

Feeling drained with migraine? New research shows that more than half of people with migraine report fatigue, and it's tied to more frequent attacks and greater disability. Molly O'Brien breaks down the details in this Migraine Minute news update. Read More:  https://bit.ly/4uNcspD   Script: More than half of people living with migraine say they also struggle with fatigue. That's according to a ne...

Insurance hurdles like prior authorization and step therapy prevent migraine patients from finding relief, but could payer blocking strategies lead to more ER and hospital visits? Molly O'Brien breaks it down the latest in this Migraine Minute news update. Read the study:  https://bit.ly/40OlvJ0 The Migraine Policy Forum: https://www.linkedin.com/company/the-headache-migraine-policy-forum/     Scr...

As April is Autism Awareness Month, we're sharing new research on the relationship between migraine and autism. A study published in Headache shows people with autism are more likely to experience migraine or headache, and symptoms may be more severe.  Molly O'Brien  breaks it down in this Migraine Minute news update. Read the Study:  https://bit.ly/3PyF3P3 Creative Commons:  https://creativecommo...

Facial pain or pressure? It might not be a sinus infection. New findings from AMD's HEADS Registry suggest migraine may be behind these symptoms for some. Molly O'Brien breaks down the research in this Migraine Minute News Update. Read more:  https://bit.ly/4aE9Dis Do you have sinus pain, dizziness, or ringing in the ears? The  HEADS Registry  is collecting patient experiences to improve care. Lea...

Analysis of the COMPEL study shows that onabotulinumtoxinA (Botox) can help reduce migraine days, lower migraine-related disability, and improve quality of life in diverse populations of chronic migraine patients. Molly O'Brien breaks down the data in this Migraine Minute News Update. Read More:  https://bit.ly/4trLxyK Researchers acknowledge that the term "race" doesn't accurately capture diverse...

Can vestibular rehab help vestibular migraine? A new review suggests that it may ease dizziness and improve daily functioning. Molly O'Brien breaks down the information in this Migraine Minute News Update. Read More: https://bit.ly/4aOHo18 Script: A new review published in Headache, The Journal of Head and Face Pain, looked at whether or not vestibular rehabilitation could be effective for vestibu...

Migraine preventive treatment benefits may go beyond fewer headache days. A new study links erenumab to improved symptoms of anxiety, depression, and poor sleep quality in some people with migraine. Molly O'Brien has the details in this Migraine Minute News Update. Read More: https://bit.ly/3LJl3r7 Script: A new study suggests that one migraine treatment may offer benefits beyond less headache day...

In a study published in  Headache , researchers identified 36 symptoms that can appear hours before a migraine attack. In this MM news update, Molly O'Brien highlights the most common symptoms, when they occur, and how recognizing these early signs can help people better treat their migraine attacks. Read more:  https://bit.ly/4ozrewr Transcript: A new study published in  Headache  is among the fi...

Our recent survey shows some people aren't aware migraine can progress—and many fear their attacks can get worse. Molly O'Brien breaks down the survey results in this MM news update. Do you worry about pain and symptoms getting worse? Let us know in the comments. Learn more:  https://www.migrainedisorders.org/migraine-disorders/migraine-treatments/ Transcript: Did you know that migraine can be a p...

Treating migraine in pregnancy can be challenging since many drugs carry risks. The good news is that the FDA updated precautions on a drug-free wearable device. Molly O'Brien has the story in this Migraine Minute News Update. Read More: http://bit.ly/4mMtfo1   Script: The FDA recently updated its precautionary language on the Nerivio neuromodulation device… removing the note that it has not been...

First-of-its-kind study: A new study suggests that a combination of THC + CBD works better than placebo, THC alone, or CBD alone for reducing migraine pain and symptoms. Molly O'Brien breaks it down in this Migraine Minute News Update . Read More:   https://bit.ly/4qvpuWo Script: For the first time, researchers tested cannabis in a placebo-controlled trial for migraine… and results suggest it coul...

A new real-world study shows atogepant (sold under brand name Qulipta) may quickly reduce migraine days—even for those who haven't responded to other treatments. Molly O'Brien has more in this Migraine Minute News Update ! Read more: http://bit.ly/3UcEuJN CC License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Script: The GIANT study, published in The Journal of Headache and Pain , offers r...

Can diabetes and weight loss drugs help with migraine relief? A new study suggests GLP-1 medications may significantly reduce migraine days. @ Molly O'Brien has more in this Migraine Minute News Update. Read More: http://bit.ly/4kGN4eO Image and license to use: Headache . 2025; 00: 1-8. http://bit.ly/47imNQO Script: GLP-1s….a drug class widely used for diabetes and weight loss treatment, may also...

A major study found that oral triptans work better for the acute treatment of migraine, than newer drugs. Molly O'Brien breaks it all down in this Migraine Minute News Update . Read more: https://bit.ly/3Wu6ZnP Images and License to use: BMJ 2024;386:e080107 http://bit.ly/4ljgU9x Script: A major international study published in the British Medical Journal found triptans to be the most effective ac...

A study in the Journal of Psychopharmacology found a surprising connection between psychedelic use and frequent bad headaches. Could psilocybin play a role in headache treatment? Molly O'Brien explains in this Migraine Minute News Update.  Read more: http://bit.ly/40k21Mu Script: A new study in the Journal of Psychopharmacology shows that people who've used psychedelics like LSD or psilocybin may...

Scientists are learning how stress may trigger a series of brain responses that could be linked to migraine, at least in mice. Molly O'Brien has more in this Migraine Minute News Update. Source: PACAP38/mast-cell-specific receptor axis mediates repetitive stress-induced headache in mice Script: A study published in the Journal of Headache and Pain explains how stress can lead to migraine pain. Res...

Two innovative DHE-based migraine treatments just earned FDA approval—offering some Americans new options for managing attacks. Molly O'Brien has details in this #MigraineMinute News Update. Read More: https://bit.ly/4kgmXMt and https://bit.ly/3SYet0c *DHE is not safe for the management of hemiplegic migraine, migraine with brainstem aura, in people with certain comorbidities, or in those who take...

Celebrating the Fourth of July with migraine is not easy. The holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O'Brien shares tips to help you enjoy the celebration while protecting your health. Check out our updated triggers webpage:  https://bit.ly/4kFOZRf Reference: https://pubmed.ncbi.nlm.nih.gov/19329386/ Script: While the Fourth of July can be...

New research shows CGRP monoclonal antibody treatment may not prevent migraine attacks triggered by the neuropeptide PACAP-38. This study suggests PACAP-38 may act through a different pathway and could become a future preventive option for people who don't respond to CGRP-based treatments. Molly O'Brien explains in this Migraine Minute News Update.  Read More: https://bit.ly/4ivy3LG Images courtes...

A study published in JAMA Neurology shows that monthly erenumab injections may help treat medication overuse headache (MOH) in people with chronic migraine. While the 140 mg dose was effective for treating MOH, the 70 mg dose did not show a meaningful difference compared to placebo. Molly O'Brien explains in this Migraine Minute News Update. Read More: https://bit.ly/4jCusxk Image Courtesy: JAMA N...

Most people with migraine go through trial and error to find a preventive treatment that works. But researchers at the Mayo Clinic may have found a way to change that. Using AI, they developed a tool to predict how someone might respond to certain migraine medications—particularly CGRP monoclonal antibodies. Molly O'Brien has more in this Migraine Minute News Update. Read More: https://bit.ly/40uK...